Document is current
Any future updates will be listed below
-
Authors
Marcos-Peña, Susana
Fernández-Pernia, Beatriz
Provan, Drew
González-López, Tomás José https://orcid.org/0000-0003-2458-2554
- License Information
-
More Information
Article History
Received: 4 June 2024
Accepted: 18 July 2024
First Online: 20 August 2024
Declarations
:
: Tomás José González-López has received research grants from Amgen and Novartis and speaker honoraria from Amgen, Novartis, Sobi, Grifols and Argenx. Drew Provan acknowledges the following competing interests: research support from Amgen, and Novartis; honoraria from Amgen, Novartis, SOBI, UCB, and Argenx; consultancies with UCB, MedImmune, Ono, SOBI, Argenx, and Takeda. Susana Marcos Peña and Beatriz Fernández-Pernia declare no competing financial interests.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
